14th Medical Education Workshop on Molecular Targeted Therapy of Cancer, Sorrento, Italy, May 10-11,2013

The Medical Education Initiative on Molecular Targeted Therapy of Cancer (MTTC), has been developed to provide high quality education programmes for medical oncologists, in response to the expanding knowledge of molecular biology and new targets for cancer therapy. ecancer members are elligible for a €50 discount on the registration fee.

During this 14th live educational workshop will be held in Sorrento, Italy on May 10-11,2013, internationally recognized oncology experts will present the latest developments in molecular biology, targets for cancer therapeutics and impact of new drugs in the clinic.

Aim of the workshop

The Medical Education Initiative on Molecular Targeted Therapy of Cancer (MTTC), established in 2001 and directed by the International Education Council (IEC), was developed to provide high quality medical education programs for medical oncologists, in response to the expanding knowledge of molecular biology and new targets for cancer therapy.

The Core Educational Curriculum comprises:

• Antibody-based therapy
• Signal transduction inhibition
• Angiogenesis inhibition
• Resistance to targeted therapies
• Cancer Immunotherapy
• Learning objectives

After attending this live educational workshop, learners will be able to:

• Recognize the basics of signal transduction, angiogenesis and immunotherapy in cancer
• Summarize the latest developments in targeted therapies for cancer
• Describe the mechanisms at the basis of  resistance to targeted therapy in cancer
• Illustrate the rationale of novel combination in molecularly targeted therapy for cancer
• Explain the current evidence in active and passive cancer immunotherapy

Target audience

Medical  oncologists  with  an  interest  in  the  molecular  basis  of cancer,  molecular  targeted  therapy  and  clinical  application  of the new drugs.

Accreditation

The  “14th International  Medical  Education  Workshop  on Molecular Targeted Therapy of Cancer - Sorrento, Italy - 10-11 May  2013”  has  been  accredited  with  10  (ten)  ESMO-MORA points Category 1.

€50 discount to the first 50 ecancer members to register to this conference!

When registering select option 2 on the registration form and then write 'ecancer' next to it. Be sure to use the same name and email as your ecancer registration.

More information on the conference can be found here.